Around 500 Reumofan Plus Tablets are undergoing a recall because they include undeclared ingredients. An analysis of a sampling found they contain two ingredients, methocarbamol and diclofenac which may lead to life-threatening reactions, anaphylaxis and hypersinsitivity. There have been no reports of adverse effects yet. The product is used for the treatment of muscle pain, arthritis, and other conditions, according to news reports.
Tags: , drug recall, drug safety, drug safety recall, ingredient safety, safety, undeclared ingredients, unsafe drugs, unsafe ingredients
Posted In: News, Personal Injury, Personal Injury Lawyers, Recall Lawyers, Recall News, Safety